These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38639925)

  • 41. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.
    Jiang M; Zhang P; Hu G; Xiao Z; Xu F; Zhong T; Huang F; Kuang H; Zhang W
    Mol Cell Biochem; 2013 Nov; 383(1-2):67-75. PubMed ID: 23881177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracellular vesicle-derived LINC00482 induces microglial M2 polarization to facilitate brain metastasis of NSCLC.
    Xu W; Patel N; Deng Y; Ding S; Wang T; Zhang H
    Cancer Lett; 2023 May; 561():216146. PubMed ID: 36963460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating miR-21-5p and miR-126-3p: diagnostic, prognostic value, and multivariate analysis in non-small-cell lung cancer.
    Soliman SE; Abdelaleem AH; Alhanafy AM; Ibrahem RAL; Elhaded ASA; Assar MFA
    Mol Biol Rep; 2021 Mar; 48(3):2543-2552. PubMed ID: 33837901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA CCAT1 promotes non-small cell lung cancer progression by regulating the miR-216a-5p/RAP2B axis.
    Pang L; Zhang Q; Wu Y; Yang Q; Zhang J; Liu Y; Li R
    Exp Biol Med (Maywood); 2021 Jan; 246(2):142-152. PubMed ID: 33023331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX; Zhou KC; Cao Y
    Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.
    Xia J; Luo M; Dai L; Wang L; Wang L; Zhu J
    J Clin Lab Anal; 2021 May; 35(5):e23743. PubMed ID: 33682961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer.
    Fu Y; Li Y; Wang X; Li F; Lu Y
    Cancer Biomark; 2020; 27(2):147-156. PubMed ID: 31771046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer.
    Zhou C; Chen Z; Zhao L; Zhao W; Zhu Y; Liu J; Zhao X
    J Clin Lab Anal; 2020 Nov; 34(11):e23505. PubMed ID: 33463758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.
    Wang F; Lou JF; Cao Y; Shi XH; Wang P; Xu J; Xie EF; Xu T; Sun RH; Rao JY; Huang PW; Pan SY; Wang H
    Exp Mol Med; 2015 May; 47(5):e162. PubMed ID: 25952770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer.
    Liao Y; Cao L; Wang F; Pang R
    J Cell Biochem; 2020 Jan; 121(1):779-787. PubMed ID: 31452243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigating miR-6880-5p in extracellular vesicle from plasma as a prognostic biomarker in endocrine therapy-treated castration-resistant prostate cancer.
    Lee J; Hong J; Kim JW; Lim S; Choi SC; Gim JA; Kang SG; Noh TI; Park KH
    BMC Cancer; 2024 Jul; 24(1):909. PubMed ID: 39075471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
    He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
    Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The long non-coding RNA MIAT/miR-139-5p/MMP2 axis regulates cell migration and invasion in non-small-cell lung cancer.
    Zeng F; Yu N; Han Y; Ainiwaer J
    J Biosci; 2020; 45():. PubMed ID: 32345777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3.
    Li M; Zhang S; Wu N; Wu L; Wang C; Lin Y
    Sci Rep; 2016 Mar; 6():23100. PubMed ID: 26972445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum Exosomal miRNA Might Be a Novel Liquid Biopsy to Identify Leptomeningeal Metastasis in Non-Small Cell Lung Cancer.
    Xu Q; Ye L; Huang L; Zhou L; Chen X; Ye M; Wu G; Zhan P; Lv T; Song Y
    Onco Targets Ther; 2021; 14():2327-2335. PubMed ID: 33833530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.